FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants
暂无分享,去创建一个
[1] M. Senjem,et al. The pimple sign of progressive supranuclear palsy syndrome. , 2014, Parkinsonism & related disorders.
[2] Isidro Ferrer,et al. Globular glial tauopathies (GGT): consensus recommendations , 2013, Acta Neuropathologica.
[3] R. Mridula,et al. Cerebral glucose metabolism, clinical, neuropsychological, and radiological profile in patients with corticobasal syndrome. , 2013, Neurology India.
[4] V. Dhawan,et al. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography , 2013, Neuroradiology.
[5] R. Buchert,et al. [18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism , 2012, Neurology.
[6] D. Berg,et al. Fluorodeoxyglucose positron emission tomography in Richardson's syndrome and progressive supranuclear palsy‐parkinsonism , 2012, Movement disorders : official journal of the Movement Disorder Society.
[7] P. Zhao,et al. 2.141 THE 18[F]-FDG PET STUDY ON THE IDIOPATHIC PARKINSON'S DISEASE AND SEVERAL PARKINSONIAN-PLUS SYNDROME , 2012 .
[8] P. Zhao,et al. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes. , 2012, Parkinsonism & related disorders.
[9] K. Leenders,et al. Typical cerebral metabolic patterns in neurodegenerative brain diseases , 2010, Movement disorders : official journal of the Movement Disorder Society.
[10] D. Dickson,et al. Neuropathology of variants of progressive supranuclear palsy. , 2010, Current opinion in neurology.
[11] Chris C. Tang,et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis , 2010, The Lancet Neurology.
[12] Jennifer L. Whitwell,et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. , 2006, Brain : a journal of neurology.
[13] Wen-Lang Lin,et al. Atypical Progressive Supranuclear Palsy With Corticospinal Tract Degeneration , 2006, Journal of neuropathology and experimental neurology.
[14] B. D. de Jong,et al. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[15] B. Choe,et al. Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis , 2005, Neuroscience Letters.
[16] Anna Barnes,et al. FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.
[17] D. Paviour,et al. Commentary on: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism, by , 2005 .
[18] B. Choe,et al. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. , 2004, European journal of radiology.
[19] M. Ohyama,et al. Midbrain hypometabolism as early diagnostic sign for progressive supranuclear palsy , 2004, Acta neurologica Scandinavica.
[20] K. Leenders,et al. Is FDG‐PET a useful tool in clinical practice for diagnosing corticobasal ganglionic degeneration? , 2003, Movement disorders : official journal of the Movement Disorder Society.
[21] 保坂 加代. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration , 2003 .
[22] A. Destée,et al. Voxel‐based distribution of metabolic impairment in corticobasal degeneration , 2000, Movement disorders : official journal of the Movement Disorder Society.
[23] S. Gilman,et al. PET measures of benzodiazepine receptors in progressive supranuclear palsy , 2000, Neurology.
[24] M. Gearing,et al. Corticobasal degeneration , 1997, Neurology.
[25] I Litvan,et al. Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.
[26] Sid Gilman,et al. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography , 1988, Annals of neurology.